Unknown

Dataset Information

0

The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P?) and hypertension (S1P?) in rat.


ABSTRACT: Sphingosine-1-phospate (S1P) and S1P receptor agonists elicit mechanism-based effects on cardiovascular function in vivo. Indeed, FTY720 (non-selective S1P(X) receptor agonist) produces modest hypertension in patients (2-3 mmHg in 1-yr trial) as well as acute bradycardia independent of changes in blood pressure. However, the precise receptor subtypes responsible is controversial, likely dependent upon the cardiovascular response in question (e.g. bradycardia, hypertension), and perhaps even species-dependent since functional differences in rodent, rabbit, and human have been suggested. Thus, we characterized the S1P receptor subtype specificity for each compound in vitro and, in vivo, the cardiovascular effects of FTY720 and the more selective S1P?,? agonist, BAF312, were tested during acute i.v. infusion in anesthetized rats and after oral administration for 10 days in telemetry-instrumented conscious rats. Acute i.v. infusion of FTY720 (0.1, 0.3, 1.0 mg/kg/20 min) or BAF312 (0.5, 1.5, 5.0 mg/kg/20 min) elicited acute bradycardia in anesthetized rats demonstrating an S1P? mediated mechanism-of-action. However, while FTY720 (0.5, 1.5, 5.0 mg/kg/d) elicited dose-dependent hypertension after multiple days of oral administration in rat at clinically relevant plasma concentrations (24-hr mean blood pressure?=?8.4, 12.8, 16.2 mmHg above baseline vs. 3 mmHg in vehicle controls), BAF312 (0.3, 3.0, 30.0 mg/kg/d) had no significant effect on blood pressure at any dose tested suggesting that hypertension produced by FTY720 is mediated S1P? receptors. In summary, in vitro selectivity results in combination with studies performed in anesthetized and conscious rats administered two clinically tested S1P agonists, FTY720 or BAF312, suggest that S1P? receptors mediate bradycardia while hypertension is mediated by S1P? receptor activation.

SUBMITTER: Fryer RM 

PROVIDER: S-EPMC3532212 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.

Fryer Ryan M RM   Muthukumarana Akalushi A   Harrison Paul C PC   Nodop Mazurek Suzanne S   Chen Rong Rhonda RR   Harrington Kyle E KE   Dinallo Roger M RM   Horan Joshua C JC   Patnaude Lori L   Modis Louise K LK   Reinhart Glenn A GA  

PloS one 20121228 12


Sphingosine-1-phospate (S1P) and S1P receptor agonists elicit mechanism-based effects on cardiovascular function in vivo. Indeed, FTY720 (non-selective S1P(X) receptor agonist) produces modest hypertension in patients (2-3 mmHg in 1-yr trial) as well as acute bradycardia independent of changes in blood pressure. However, the precise receptor subtypes responsible is controversial, likely dependent upon the cardiovascular response in question (e.g. bradycardia, hypertension), and perhaps even spec  ...[more]

Similar Datasets

| S-EPMC4027137 | biostudies-literature
2017-01-09 | GSE85339 | GEO
| S-EPMC7456236 | biostudies-literature
| S-EPMC4704178 | biostudies-literature
| S-EPMC5680089 | biostudies-literature
| S-EPMC6117120 | biostudies-literature
| S-EPMC5153655 | biostudies-literature
| S-EPMC5707436 | biostudies-literature